389 related articles for article (PubMed ID: 17854599)
1. Evidence against a role for NADPH oxidase modulating hepatic vascular tone in cirrhosis.
Gracia-Sancho J; Laviña B; Rodríguez-Vilarrupla A; Brandes RP; Fernández M; Bosch J; García-Pagán JC
Gastroenterology; 2007 Sep; 133(3):959-66. PubMed ID: 17854599
[TBL] [Abstract][Full Text] [Related]
2. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
[TBL] [Abstract][Full Text] [Related]
3. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.
Schlüter T; Steinbach AC; Steffen A; Rettig R; Grisk O
Cardiovasc Res; 2008 Nov; 80(2):271-9. PubMed ID: 18596059
[TBL] [Abstract][Full Text] [Related]
4. Large-conductance calcium-activated potassium channels modulate vascular tone in experimental cirrhosis.
Rodríguez-Vilarrupla A; Graupera M; Matei V; Bataller R; Abraldes JG; Bosch J; García-Pagán JC
Liver Int; 2008 Apr; 28(4):566-73. PubMed ID: 18339082
[TBL] [Abstract][Full Text] [Related]
5. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats.
Abraldes JG; Rodríguez-Vilarrupla A; Graupera M; Zafra C; García-Calderó H; García-Pagán JC; Bosch J
J Hepatol; 2007 Jun; 46(6):1040-6. PubMed ID: 17335931
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow.
Belin de Chantemèle EJ; Vessières E; Guihot AL; Toutain B; Maquignau M; Loufrani L; Henrion D
Cardiovasc Res; 2009 Mar; 81(4):788-96. PubMed ID: 19050009
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers.
Graupera M; García-Pagán JC; Abraldes JG; Peralta C; Bragulat M; Corominola H; Bosch J; Rodés J
Hepatology; 2003 Jan; 37(1):172-81. PubMed ID: 12500202
[TBL] [Abstract][Full Text] [Related]
10. Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers.
Graupera M; March S; Engel P; Rodés J; Bosch J; García-Pagán JC
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G763-70. PubMed ID: 15550559
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats.
Edirimanne VE; Woo CW; Siow YL; Pierce GN; Xie JY; O K
Can J Physiol Pharmacol; 2007 Dec; 85(12):1236-47. PubMed ID: 18066125
[TBL] [Abstract][Full Text] [Related]
12. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
[TBL] [Abstract][Full Text] [Related]
13. Chronic administration of genistein improves endothelial dysfunction in spontaneously hypertensive rats: involvement of eNOS, caveolin and calmodulin expression and NADPH oxidase activity.
Vera R; Sánchez M; Galisteo M; Villar IC; Jimenez R; Zarzuelo A; Pérez-Vizcaíno F; Duarte J
Clin Sci (Lond); 2007 Feb; 112(3):183-91. PubMed ID: 17007611
[TBL] [Abstract][Full Text] [Related]
14. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats.
Gupta TK; Toruner M; Chung MK; Groszmann RJ
Hepatology; 1998 Oct; 28(4):926-31. PubMed ID: 9755227
[TBL] [Abstract][Full Text] [Related]
16. Chronic escitalopram treatment induces erectile dysfunction by decreasing nitric oxide bioavailability mediated by increased nicotinamide adenine dinucleotide phosphate oxidase activity and reactive oxygen species production.
Kassan M; Lasker GF; Sikka SC; Mandava SH; Gokce A; Matrougui K; Hellstrom WJ; Kadowitz PJ; Serefoglu EC
Urology; 2013 Nov; 82(5):1188.e1-7. PubMed ID: 24242893
[TBL] [Abstract][Full Text] [Related]
17. NADPH oxidase accounts for enhanced superoxide production and impaired endothelium-dependent smooth muscle relaxation in BKbeta1-/- mice.
Oelze M; Warnholtz A; Faulhaber J; Wenzel P; Kleschyov AL; Coldewey M; Hink U; Pongs O; Fleming I; Wassmann S; Meinertz T; Ehmke H; Daiber A; Münzel T
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1753-9. PubMed ID: 16763163
[TBL] [Abstract][Full Text] [Related]
18. The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis.
Matei V; Rodríguez-Vilarrupla A; Deulofeu R; Colomer D; Fernández M; Bosch J; Garcia-Pagán JC
Hepatology; 2006 Jul; 44(1):44-52. PubMed ID: 16799985
[TBL] [Abstract][Full Text] [Related]
19. Adventitial application of the NADPH oxidase inhibitor apocynin in vivo reduces neointima formation and endothelial dysfunction in rabbits.
Chan EC; Datla SR; Dilley R; Hickey H; Drummond GR; Dusting GJ
Cardiovasc Res; 2007 Sep; 75(4):710-8. PubMed ID: 17659266
[TBL] [Abstract][Full Text] [Related]
20. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
